Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -7.79% is 29% below its 5-year average of -6.03%, around the middle of its 5-year range (-37.68%–28.68%).
16.73% below its 12-month average of -6.67%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2.59%.
NET PROFIT MARGIN
-7.79%
NET PROFIT MARGIN AVG TTM
-6.67%
NET PROFIT MARGIN AVG 3Y
-5.16%
NET PROFIT MARGIN AVG 5Y
-6.03%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-16.73%
CURRENT VS 3Y AVG
-51.06%
CURRENT VS 5Y AVG
-29.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 565 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
AirSculpt Technologies, Inc.
Market Cap
$139.95M
Net Profit Margin
-7.79%
TTM Avg
-6.67%
3Y Avg
-5.16%
5Y Avg
-6.03%
Market Cap
$140.09M
Net Profit Margin
-153.61%
TTM Avg
-101.12%
3Y Avg
-50.56%
5Y Avg
-33.71%
Market Cap
$141.70M
Net Profit Margin
163.32%
TTM Avg
-34.49%
3Y Avg
-63.76%
5Y Avg
-75.19%
Market Cap
$137.57M
Net Profit Margin
-4.03%
TTM Avg
-12.22%
3Y Avg
-25.92%
5Y Avg
-21.35%
Market Cap
$142.72M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$135.83M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$144.79M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3984.32%
5Y Avg
-3047.80%
Market Cap
$146.71M
Net Profit Margin
-353.00%
TTM Avg
-161.48%
3Y Avg
-3791.01%
5Y Avg
-3351.38%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AirSculpt Technologies, Inc. (AIRS) | $139.95M | -7.79% | -6.67% | -5.16% | -6.03% |
| Alpha Cognition Inc (ACOG)vs › | $140.09M | -153.61% | -101.12% | -50.56% | -33.71% |
| Freenome, Inc. (FRNM)vs › | $138.47M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $141.70M | 163.32% | -34.49% | -63.76% | -75.19% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.57M | -4.03% | -12.22% | -25.92% | -21.35% |
| LifeMD, Inc. (LFMDP)vs › | $142.72M | -10.40% | -6.28% | -16.07% | -47.85% |
| LifeMD, Inc. (LFMD)vs › | $135.83M | -10.40% | -6.28% | -16.07% | -47.85% |
| Immuneering Corporation (IMRX)vs › | $144.79M | 0.00% | 0.00% | -3984.32% | -3047.80% |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.71M | -353.00% | -161.48% | -3791.01% | -3351.38% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $148.07M | 0.00% | 0.00% | 0.00% | -85.02% |
Operating Margin
-7.8%
Net Profit Margin
-7.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2.59% |
| 2026-03-31 | -6.09% |
| 2025-12-31 | 3.84% |
| 2025-09-30 | -27.18% |
| 2025-06-30 | -1.34% |
| 2025-03-31 | -7.23% |
| 2024-12-31 | -12.85% |
| 2024-09-30 | -14.20% |
| 2024-06-30 | -6.29% |
| 2024-03-31 | 12.66% |
| 2023-12-31 | -9.61% |
| 2023-09-30 | -3.56% |
| 2023-06-30 | 3.19% |
| 2023-03-31 | -0.03% |
| 2022-12-31 | -17.67% |
| 2022-09-30 | -18.97% |
| 2022-06-30 | 1.17% |
| 2022-03-31 | -1.75% |
| 2021-12-31 | -37.68% |
| 2021-09-30 | 23.24% |
| 2021-06-30 | 28.68% |
| 2021-03-31 | 25.33% |
| 2020-12-31 | 18.54% |
| 2020-09-30 | 13.58% |
| 2020-06-30 | -4.11% |
| 2020-03-31 | -4.11% |
